- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 333/80 - Cycles à sept chaînons
Détention brevets de la classe C07D 333/80
Brevets de cette classe: 29
Historique des publications depuis 10 ans
|
0
|
5
|
3
|
5
|
3
|
0
|
0
|
3
|
0
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Enyo Pharma | 53 |
3 |
| The Regents of the University of California | 20802 |
2 |
| Syngenta Participations AG | 1513 |
2 |
| Shanghai Yuyao Biotech Ltd. | 12 |
2 |
| Codagen Biosciences, Inc. | 5 |
2 |
| DuPont Specialty Materials Korea Ltd. | 305 |
2 |
| LG Chem, Ltd. | 17937 |
1 |
| ACADIA Pharmaceuticals Inc. | 192 |
1 |
| Astellas Pharma Inc. | 1039 |
1 |
| Daegu Gyeongbuk Institute of Science and Technology | 767 |
1 |
| Icahn School of Medicine at Mount Sinai | 1044 |
1 |
| Rohm and Haas Electronic Materials Korea Ltd. | 332 |
1 |
| Rutgers, The State University of New Jersey | 1977 |
1 |
| University of Iowa Research Foundation | 863 |
1 |
| University of Kentucky Research Foundation | 714 |
1 |
| sanofi-aventis | 295 |
1 |
| Shanghai Nichem Fine Chemical Co., Ltd. | 3 |
1 |
| LT Materials Co., Ltd. | 445 |
1 |
| Scandiedge Therapeutics AB | 10 |
1 |
| Zomagen Biosciences Ltd | 19 |
1 |
| Autres propriétaires | 2 |